Oric Pharmaceuticals, Inc. (NASDAQ: ORIC)
$8.5100
+0.0100 ( -6.79% ) 551.5K
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
Market Data
Open
$8.5100
Previous close
$8.5000
Volume
551.5K
Market cap
$599.82M
Day range
$8.3150 - $9.2300
52 week range
$6.3300 - $16.6500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 17, 2024 |
| 4 | Insider transactions | 1 | Dec 17, 2024 |
| 4 | Insider transactions | 1 | Dec 17, 2024 |
| 10-q | Quarterly Reports | 49 | Nov 12, 2024 |
| 8-k | 8K-related | 13 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 50 | Aug 12, 2024 |
| 8-k | 8K-related | 13 | Aug 12, 2024 |
| 4 | Insider transactions | 1 | Jun 14, 2024 |
| 4 | Insider transactions | 1 | Jun 14, 2024 |
| 8-k | 8K-related | 13 | Jun 14, 2024 |